Clinical Application of Metformin Use in Anhui Province, China: A Cross-Sectional Study

References

• IDF_Atlas_10th_Edition_2021; 2021. Available from: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf. Accessed Dec 20, 2021.
   Google Scholar
• Society CD. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes Mellit. 2021;13(4):315–409.
   Google Scholar
• Draznin B, Aroda VR, Bakris G, et al.; American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl1):S125–125S143. doi:10.2337/dc22-S009
   PubMedGoogle Scholar
• Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021;9(3):174–188. doi:10.1016/S2213-8587(20)30381-8
   PubMed Web of Science ®Google Scholar
• Le S, Lee GC. Emerging trends in metformin prescribing in the United States from 2000 to 2015. Clin Drug Investig. 2019;39(8):757–763. doi:10.1007/s40261-019-00799-0
   PubMed Web of Science ®Google Scholar
• Haymana C, Sonmez A, Demirci I, et al. Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes - A nationwide cross-sectional study (TEMD treatment study). Diabetes Res Clin Pract. 2021;171:108556. doi:10.1016/j.diabres.2020.108556
   PubMed Web of Science ®Google Scholar
• Yang A, Wu H, Lau E, et al. Trends in glucose-lowering drug use, glycemic control, and severe hypoglycemia in adults with diabetes in Hong Kong, 2002–2016. Diabetes Care. 2020;43(12):2967–2974. doi:10.2337/dc20-0260
   PubMed Web of Science ®Google Scholar
• McEwen LN, Hurst TE, Joiner KL, Herman WH. Health beliefs associated with metformin use among insured adults with prediabetes. Diabetes Care. 2022;45(10):2282–2288. doi:10.2337/dc21-2316
   PubMed Web of Science ®Google Scholar
• Tseng E, Greer RC, O’Rourke P, et al. National survey of primary care physicians’ knowledge, practices, and perceptions of prediabetes. J Gen Intern Med. 2019;34(11):2475–2481. doi:10.1007/s11606-019-05245-7
   PubMed Web of Science ®Google Scholar
• Liu C, Foti K, Grams ME, Shin JI, Selvin E. Trends in self-reported prediabetes and metformin use in the USA: NHANES 2005–2014. J Gen Intern Med. 2020;35(1):95–101. doi:10.1007/s11606-019-05398-5
   PubMed Web of Science ®Google Scholar
• Liu C, Tang S, An K, et al. Knowledge, attitude, and practice of metformin extended-release tablets among clinicians in China: a cross-sectional survey. Front Pharmacol. 2021;12:634561. doi:10.3389/fphar.2021.634561
   PubMed Web of Science ®Google Scholar
• Khan T, Wozniak GD, Kirley K. An assessment of medical students’ knowledge of prediabetes and diabetes prevention. BMC Med Educ. 2019;19(1):285. doi:10.1186/s12909-019-1721-9
   PubMedGoogle Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015;58(3):429–442. doi:10.1007/s00125-014-3460-0
   PubMed Web of Science ®Google Scholar
• Seferović PM, Petrie MC, Filippatos GS, et al. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(5):853–872. doi:10.1002/ejhf.1170
   PubMed Web of Science ®Google Scholar
• Mu YM; Expert Group of Metformin in Clinical Practice. Expert consensus on clinical use of metformin (2018 edition). Chin J Diabetes. 2019;27(3):161–173. doi:10.3969/j.issn.1006-6187.2019.03.001
   Google Scholar
• Gu XC, Men P, Zhai SD. Questionnaire survey on pharmacists’s attitude to safety and efficacy of original patented drug and generic drug of metformin. China Acad J. 2017;37(13):1292–1294+1301.
   Google Scholar
• Liu C, Zhou YL, Wang Y, et al. Knowledge, attitude and practice of metformin hydrochloride sustained release tablets in outpatients with type 2 diabetes mellitus. Chin Gen Pract. 2021;24(36):4593–4598.
   Google Scholar
• Hashimoto Y, Yasuzawa H, Ishida T, Miyazaki Y, Fukui M. A survey on consciousness towards the proper use of metformin and medical cost in Japanese patients with type 2 diabetes. J Clin Biochem Nutr. 2021;69(3):286–293. doi:10.3164/jcbn.21-5
   PubMed Web of Science ®Google Scholar
• Guo T, Guo LX, Weng JP and Zhou ZG. Chinese guidelines for insulin treatment of type 1 diabetes mellitus. Chin J Diabetes Mellit. 2016;8:591–597.
   Google Scholar
• Amiel SA, Pursey N, Higgins B, Dawoud D. Type 1 Diabetes in Adults: Diagnosis and Management. London: National Institute for Health and Care Excellence (NICE); 2022.
   Google Scholar
• Bjornstad P, Schäfer M, Truong U, et al. Metformin improves insulin sensitivity and vascular health in youth with type 1 diabetes mellitus. Circulation. 2018;138(25):2895–2907. doi:10.1161/CIRCULATIONAHA.118.035525
   PubMed Web of Science ®Google Scholar
• Draznin B; American Diabetes Association Professional Practice Committee, American Diabetes Association Professional Practice Committee. Management of diabetes in pregnancy: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl1):S232–232S243. doi:10.2337/dc22-S015
   PubMedGoogle Scholar
• Hanem L, Stridsklev S, Júlíusson PB, et al. Metformin use in PCOS pregnancies increases the risk of offspring overweight at 4 years of age: follow-up of two RCTs. J Clin Endocrinol Metab. 2018;103(4):1612–1621. doi:10.1210/jc.2017-02419
   PubMed Web of Science ®Google Scholar
• Hanem L, Salvesen Ø, Juliusson PB, et al. Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5–10 year follow-up of the PregMet randomised controlled trial. Lancet Child Adolesc Health. 2019;3(3):166–174. doi:10.1016/S2352-4642(18)30385-7
   PubMedGoogle Scholar
• Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med. 2019;16(8):e1002848. doi:10.1371/journal.pmed.1002848
   PubMed Web of Science ®Google Scholar
• Lv Z, Guo Y. Metformin and its benefits for various diseases. Front Endocrinol. 2020;11:191. doi:10.3389/fendo.2020.00191
   PubMed Web of Science ®Google Scholar
• NICE guideline. Type 2 diabetes in adults: management. Available from: https://www.nice.org.uk/guidance/ng28/chapter/Recommendations.; 2022 Accessed August 20, 2022.
   Google Scholar
• Tan J, Wang Y, Liu S, et al. Long-acting metformin vs. metformin immediate release in patients with type 2 diabetes: a systematic review. Front Pharmacol. 2021;12:669814. doi:10.3389/fphar.2021.669814
   PubMed Web of Science ®Google Scholar
• Guo L, Guo X, Li Y, et al. Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: sub-analysis of a Phase IV open-label trial in Chinese patients. Diabetes Metab Syndr. 2016;10(3):137–142. doi:10.1016/j.dsx.2016.01.004
   PubMedGoogle Scholar
• Bonnet F, Scheen A. Understanding and overcoming metformin gastrointestinal intolerance. Diabetes Obes Metab. 2017;19(4):473–481. doi:10.1111/dom.12854
   PubMed Web of Science ®Google Scholar
• U.S. FaDA. FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function; 2016.
   Google Scholar
• Ekström N, Schiöler L, Svensson AM, et al. Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2012;2:4. doi:10.1136/bmjopen-2012-001076
   Web of Science ®Google Scholar
• Dissanayake AM, Wheldon MC, Ahmed J, Hood CJ. Extending metformin use in diabetic kidney disease: a pharmacokinetic study in stage 4 diabetic nephropathy. Kidney Int Rep. 2017;2(4):705–712. doi:10.1016/j.ekir.2017.03.005
   PubMed Web of Science ®Google Scholar
• Lalau JD, Kajbaf F, Bennis Y, Hurtel-Lemaire AS, Belpaire F, De Broe ME. Metformin treatment in patients with type 2 diabetes and chronic kidney disease stages 3A, 3B, or 4. Diabetes Care. 2018;41(3):547–553. doi:10.2337/dc17-2231
   PubMed Web of Science ®Google Scholar
• Singh S, Singh PP, Singh AG, Murad MH, Sanchez W. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis. Am J Gastroenterol. 2013;108(6):881–891; quiz 892. doi:10.1038/ajg.2013.5
   PubMed Web of Science ®Google Scholar
• Pinyopornpanish K, Leerapun A, Pinyopornpanish K, Chattipakorn N. Effects of metformin on hepatic steatosis in adults with nonalcoholic fatty liver disease and diabetes: insights from the cellular to patient levels. Gut Liver. 2021;15(6):827–840. doi:10.5009/gnl20367
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang X, Yan C, et al. Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology. Medicine. 2022;101(43):e31437. doi:10.1097/MD.0000000000031437
   PubMed Web of Science ®Google Scholar
• Orloff J, Min JY, Mushlin A, Flory J. Safety and effectiveness of metformin in patients with reduced renal function: a systematic review. Diabetes Obes Metab. 2021;23(9):2035–2047. doi:10.1111/dom.14440
   PubMed Web of Science ®Google Scholar
• Bergmark BA, Bhatt DL, McGuire DK, et al. Metformin use and clinical outcomes among patients with diabetes mellitus with or without heart failure or kidney dysfunction: observations from the SAVOR-TIMI 53 Trial. Circulation. 2019;140(12):1004–1014. doi:10.1161/CIRCULATIONAHA.119.040144
   PubMed Web of Science ®Google Scholar
• Han Y, Xie H, Liu Y, Gao P, Yang X, Shen Z. Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis. Cardiovasc Diabetol. 2019;18(1):96. doi:10.1186/s12933-019-0900-7
   PubMedGoogle Scholar
• Tseng CH. Metformin use is associated with a lower risk of hospitalization for heart failure in patients with type 2 diabetes mellitus: a retrospective cohort analysis. J Am Heart Assoc. 2019;8(21):e011640. doi:10.1161/JAHA.118.011640
   PubMed Web of Science ®Google Scholar